Satellite symposium1  Sponsored by Novonordisk Thursday 16 October 17:30~18:00 | Place: Room 2
Chair: Sei Hyun Baik
Hyuk Sang Kwon
The Catholic University of Korea, Korea

SS1

The new solution to T2DM: human GLP-1 analogue, liraglutide

Satellite symposium2  Sponsored by Lilly Thursday 16 October 17:30~18:00 | Place: Room 3
Chair: Jae Myung Yu
Jae Hyuk Lee
Myongji Hospital, Korea

SS2

The role of pre-mixed insulin for patients with T2DM comparing with basal insulin treatment

Breakfast symposium 1  Sponsored by Daewoong Friday 17 October 07:00~08:00 | Place: Grand Ballroom, MVL Hotel
Chair: Yong Seong Kim
Woo Je Lee
University of Ulsan, Korea

BS1

Importance of awareness about hypoglycemia risk and prevention of cardio vascular complications in T2DM

Breakfast symposium 2  Sponsored by Takeda Friday 17 October 07:00~08:00 | Place: Grand Ballroom, MVL Hotel
Chair: Kyung Soo Ko
Eun Jung Rhee
Sungkyunkwan University, Korea

BS2

Efficacy and durability: it's time to think of 10-year plan for our patients

Breakfast symposium 3  Sponsored by Boehringer Ingelheim Saturday 18 October 07:30~08:30 | Place: Grand Ballroom, MVL Hotel
Chair: Han Kyung Ah
Eun Seok Kang
Yonsei University, Korea

BS3

DPP4 inhibitor, Linagliptin, to simplify treatment for a broad range of T2DM patients (2014 ADA highlight)

Breakfast symposium 4  Sponsored by Handok Saturday 18 October 07:30~08:30 | Place: Grand Ballroom, MVL Hotel
Chair: Kang Seo Park
Eun Gyoung Hong
Hallym University, Korea

BS4

Metabolic karma - the essential solution in T2DM

Luncheon symposium 1 Sponsored by MSD Friday 17 October 11:50~13:00 | Place: Room 2
Chair: Yong Ki Kim
Cheol-Young Park
Sungkyunkwan University, Korea

LS1

Comprehensive approach for diabetic dyslipidemia management

Luncheon symposium 2 Sponsored by Astrazeneca Friday 17 October 11:50~13:00 | Place: Room 3
Chair: Seok Won Park
Young Min Cho
Seoul National University, Korea

LS2

"Update on emerging novel agents for the treatment of type 2 diabetes: focus on dapagliflozin

Luncheon symposium 3 Sponsored by Sanofi Aventis Friday 17 October 11:50~13:00 | Place: Room 4
Chair: Hak Chul Jang
Sung Hee Choi
Seoul National University, Korea

LS3

Management of hyperglycemia in patients with type 2 diabetes uncontrolled on a combination of sulfonylurea and metformin: results of MOHAS disease registry in Korea

Luncheon symposium 4 Sponsored by Otsuka Friday 17 October 11:50~13:00 | Place: Room 5
Chair: Cheol Soo Choi
Kyoung Im Cho
Kosin University, Korea

LS4

Benefit of carotid ultrasonography and antiplatelet therapy for diabetic patients

Luncheon symposium 5 Sponsored by Novartis Saturday 18 October 12:10~13:30 | Place: Room 2
Chair: Sung-Soo Koong
Kyung Mook Choi
Korea University, Korea

LS5

Destination diabetes: exploring the pathways and junctions of the T2DM

Luncheon symposium 6 Sponsored by JW Pharmaceutical Saturday 18 October 12:10~13:30 | Place: Room 3
Chair: Kyung Ho Lim
Koutaro Yokote
Chiba University, Japan

LS6

Lipid management in diabetes: potential role of pitavastatin in Asian patients

Luncheon symposium 7 Sponsored by Pfizer Saturday 18 October 12:10~13:30 | Place: Room 4
Chair: Kyu Jeung Ahn
In-Kyung Jeong
Kyung-Hee University, Korea

LS7

Novel approach of dyslipidemia management in T2DM based on updated guideline & clinical trial

Quick Menu
Registration
Abstract
On-line submission
Venue
venue
Top